The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the 62092-22092 STRASS trial.
 
Rick L.M. Haas
Honoraria - Nanobiotix; PharmaMar; SpringWorks Therapeutics (Inst)
Consulting or Advisory Role - Nanobiotix
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Nanobiotix; Nanobiotix
 
Jean-Jacques Stelmes
No Relationships to Disclose
 
Facundo Zaffaroni
No Relationships to Disclose
 
Enrico Clementel
No Relationships to Disclose
 
Raquel Bar Deroma
No Relationships to Disclose
 
Cecile Le Pechoux
Honoraria - Lilly (Inst); Medscape (Inst); Prime Oncology
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Nanobiotix (Inst); Roche (Inst)
 
Saskia Litiere
No Relationships to Disclose
 
Sandrine Marreaud
No Relationships to Disclose
 
Najlaa Alyamani
No Relationships to Disclose
 
Nicolaus Andratschke
Honoraria - AstraZeneca; Debiopharm Group
Research Funding - Brainlab (Inst); ViewRay (Inst)
Travel, Accommodations, Expenses - ViewRay
 
Claudia Sangalli
No Relationships to Disclose
 
Peter W. M. Chung
No Relationships to Disclose
 
Aisha Miah
No Relationships to Disclose
 
Coen Hurkmans
No Relationships to Disclose
 
Alessandro Gronchi
Honoraria - Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar; SpringWorks Therapeutics
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar
 
Judith V.M.G. Bovée
No Relationships to Disclose
 
Hans Gelderblom
Research Funding - Daiichi (Inst); Deciphera (Inst); Ipsen (Inst); Novartis (Inst)
 
Bernd Kasper
No Relationships to Disclose
 
Damien Weber
No Relationships to Disclose
 
Sylvie Bonvalot
No Relationships to Disclose